Rhythm Pharmaceuticals, Inc. (RYTM)

Rhythm Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	47.52	60.08	127.68	59.25	100.85	62.29
Short-Term Investments	250.87	215.77	205.61	235.61	71.94	230.17
Cash & Short-Term Investments	298.39	275.85	333.29	294.86	172.79	292.46
Cash Growth	-0.29%	-17.23%	13.03%	70.64%	-40.92%	16.03%
Receivables	19.31	14.87	6.22	1.03	-	-
Inventory	13.9	8.62	2.92	0.11	-	-
Prepaid Expenses	8.75	-	-	-	-	-
Other Current Assets	-	8.93	11.81	12.4	8.88	9.95
Total Current Assets	340.34	308.27	354.24	308.39	181.67	302.4
Property, Plant & Equipment	4.39	2.12	3.38	4.34	5	5.72
Other Intangible Assets	6.39	7.03	7.88	4.66	-	-
Other Long-Term Assets	12.45	15.33	16.98	12.14	0.4	0.4
Total Assets	363.57	332.75	382.48	329.52	187.07	308.52
Accounts Payable	4.89	4.89	4.8	5.74	4.9	10.42
Accrued Expenses	50.48	48.26	32.89	29.26	12.56	13.53
Current Portion of Leases	-	0.77	0.68	0.61	0.54	0.47
Current Unearned Revenue	1.29	1.29	1.43	7	-	-
Other Current Liabilities	40.95	-	-	0.83	-	-
Total Current Liabilities	97.61	55.2	39.81	43.43	17.99	24.42
Long-Term Debt	109.24	106.14	75.81	-	-	-
Long-Term Leases	4.03	0.49	1.26	1.95	2.55	3.09
Other Long-Term Liabilities	-	1.15	1.34	-	-	-
Total Liabilities	210.88	162.99	118.22	45.37	20.55	27.5
Common Stock	0.06	0.06	0.06	0.05	0.04	0.04
Additional Paid-In Capital	1,124	1,064	974.36	813.04	625.76	606.31
Retained Earnings	-1,112	-894.74	-710.06	-528.94	-459.33	-325.33
Comprehensive Income & Other	-0.6	0.13	-0.09	-0	0.05	-
Total Common Equity	11.22	169.76	264.26	284.15	166.53	281.02
Shareholders' Equity	152.7	169.76	264.26	284.15	166.53	281.02
Total Liabilities & Equity	363.57	332.75	382.48	329.52	187.07	308.52
Total Debt	113.27	107.4	77.75	2.55	3.09	3.56
Net Cash (Debt)	185.12	168.44	255.53	292.3	169.71	288.9
Net Cash Growth	-37.84%	-34.08%	-12.58%	72.24%	-41.26%	14.62%
Net Cash Per Share	3.06	2.92	4.90	5.89	3.85	7.93
Filing Date Shares Outstanding	61.46	60.14	56.75	50.33	50.18	44.06
Total Common Shares Outstanding	61.44	59.43	56.61	50.28	44.24	44
Working Capital	242.74	253.07	314.43	264.96	163.67	277.99
Book Value Per Share	0.18	2.86	4.67	5.65	3.76	6.39
Tangible Book Value	4.83	162.73	256.38	279.49	166.53	281.02
Tangible Book Value Per Share	0.08	2.74	4.53	5.56	3.76	6.39
Machinery	-	2.7	2.65	2.37	1.93	1.72
Leasehold Improvements	-	2.71	2.71	2.71	2.71	2.71

Source: S&P Capital IQ. Standard template. Financial Sources.